Santoro, N., Waldbaum, A., Lederman, S., Kroll, R., Fraser, G. L., Lademacher, C., . . . Ramael, S. (2020). Effect of the neurokinin 3 receptor antagonist fezolinetant on patient-reported outcomes in postmenopausal women with vasomotor symptoms: Results of a randomized, placebo-controlled, double-blind, dose-ranging study (VESTA). Menopause.

Santoro, Nanette, Arthur Waldbaum, Samuel Lederman, Robin Kroll, Graeme L. Fraser, Christopher Lademacher, Laurence Skillern, James Young, and Steven Ramael. "Effect of the Neurokinin 3 Receptor Antagonist Fezolinetant On Patient-reported Outcomes in Postmenopausal Women With Vasomotor Symptoms: Results of a Randomized, Placebo-controlled, Double-blind, Dose-ranging Study (VESTA)." Menopause 2020.

Santoro, Nanette, et al. "Effect of the Neurokinin 3 Receptor Antagonist Fezolinetant On Patient-reported Outcomes in Postmenopausal Women With Vasomotor Symptoms: Results of a Randomized, Placebo-controlled, Double-blind, Dose-ranging Study (VESTA)." Menopause 2020.